{"id":"W4405658451","doi":"10.1161/jaha.124.037577","title":"Safety and Efficacy of Intravenous Thrombolysis by Infarct Type in Patients with No Visible Occlusion: A Secondary Analysis of the AcT Trial","year":2024,"lang":"en","type":"article","venue":"Journal of the American Heart Association","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Queen's University; University of British Columbia; Sunnybrook Health Science Centre; Kelowna General Hospital; St. Michael's Hospital; University of Ottawa; McMaster University; Hamilton Health Sciences; Health Sciences Centre; Ottawa Hospital; University of Manitoba; Ontario Brain Institute; University of Saskatchewan; University of Alberta; University of Calgary","funders":"Canadian Institutes of Health Research; Alberta Innovates; Heart and Stroke Foundation of Canada","keywords":"Medicine; Tenecteplase; Thrombolysis; Occlusion; Stroke (engine); Fibrinolytic agent; Internal medicine; Cardiology; Clinical trial; Myocardial infarction; Anesthesia; Tissue plasminogen activator","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007650133,0.00116298,0.002181748,0.0006813068,0.0004180619,0.001427234,0.0005837111,0.000793975,0.0034425],"category_scores_gemma":[0.009810845,0.000317888,0.004216981,0.0007893465,0.0004976006,0.0007278721,0.0005547127,0.001932017,0.0006945838],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00047253,"about_ca_system_score_gemma":0.0007547871,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006888817,"about_ca_topic_score_gemma":0.0009316853,"domain_scores_codex":[0.9939272,0.004049032,0.0004642509,0.00062877,0.0006150056,0.0003157964],"domain_scores_gemma":[0.988063,0.004775283,0.003369424,0.00155259,0.001435413,0.0008042211],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.8549189,0.00251908,0.09931355,0.001381542,0.01761861,0.0002491285,0.0001713387,0.001350265,0.002691941,0.0007536592,0.007341987,0.01169],"study_design_scores_gemma":[0.4169818,0.08587371,0.4179578,0.000432821,0.04990606,0.001246476,0.0002260747,0.008366989,0.004263957,0.002898925,0.01160191,0.0002435921],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9852197,0.003107564,0.001043658,0.0003494934,0.0002473365,0.0009596845,0.005949277,0.00004856323,0.003074706],"genre_scores_gemma":[0.9874725,0.0005794549,0.0007358906,0.0003835602,0.0005555865,0.001408254,0.00760561,0.00003805582,0.001221117],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007650133,"threshold_uncertainty_score":0.04045826,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.004129539995400489,"score_gpt":0.2497113964228772,"score_spread":0.2455818564274767,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}